On Wednesday, 73 stocks hit new 52-week lows.
May 16, 5:42 PM
Albireo Pharma (NASDAQ:ALBO) reported its Q1 earnings results on Monday, May 16, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Albireo Pharma missed estimated earnings by 18.38%, reporting an EPS of $-2.19 versus an estimate of $-1.85.
March 1, 9:41 AM
Albireo Pharma (NASDAQ:ALBO) reported quarterly losses of $(0.57) per share which beat the analyst consensus estimate of $(1.35) by 57.78 percent. This is a 56.15 percent increase over losses of $(1.30) per share from
December 27, 12:12 PM
Biotech stocks remain poised to eke out modest gains for 2021 after the stellar gains of the previous year. COVID-19 drug and vaccine developers experienced volatility throughout 2021 amid delays in programs and the reemergence of variant strains.
November 5, 12:42 PM
HC Wainwright & Co. analyst Ed Arce maintains Albireo Pharma (NASDAQ:ALBO) with a Buy and raises the price target from $79 to $80.